Amanote Research
Register
Sign In
Phosphodiesterase-5 Inhibitors Improve Left Ventricular Function in Failing Hearts
doi 10.5772/30035
Full Text
Open PDF
Abstract
Available in
full text
Date
January 18, 2012
Authors
Fadi N.
Rakesh C.
Publisher
InTech
Related search
Sarcoplasmic Reticulum-Associated Cyclic Adenosine 5'-Monophosphate Phosphodiesterase Activity in Normal and Failing Human Hearts.
Journal of Clinical Investigation
Medicine
Mechanical Dyssynchrony Alters Left Ventricular Flow Energetics in Failing Hearts With LBBB: A 4D Flow CMR Pilot Study
International Journal of Cardiovascular Imaging
Nuclear Medicine
Radiology
Cardiovascular Medicine
Imaging
Cardiology
Phosphodiesterase-5 Inhibitors: Emerging Nephroprotective Drugs
Anatolian journal of cardiology
Cardiovascular Medicine
Cardiology
Phosphodiesterase 5 Associates With Β2 Adrenergic Receptor to Modulate Cardiac Function in Type 2 Diabetic Hearts
Journal of the American Heart Association
Cardiovascular Medicine
Cardiology
Oxygen Costs of Left Ventricular Contractility for Dobutamine and Ca2+ in Normal Rat Hearts and the Cost for Dobutamine in Ca2+ Overload-Induced Failing Hearts.
The Japanese Journal of Physiology
Regulation of Myofilament Contractile Function in Human Donor and Failing Hearts
Biophysical Journal
Biophysics
AB030. Evolution of Phosphodiesterase Type 5 Inhibitors
Translational Andrology and Urology
Reproductive Medicine
Urology
Effect of Left Ventricular Dysfunction on Utilization of Donor Hearts
Journal of Heart and Lung Transplantation
Cardiology
Transplantation
Cardiovascular Medicine
Pulmonary
Respiratory Medicine
Surgery
Left Ventricular Function: Time-Varying Elastance and Left Ventricular Aortic Coupling
Critical Care
Critical Care
Intensive Care Medicine
